Central Bank & Trust’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-960
Closed -$77K 357
2016
Q4
$77K Hold
960
0.02% 166
2016
Q3
$77K Hold
960
0.02% 158
2016
Q2
$75K Hold
960
0.02% 158
2016
Q1
$53K Hold
960
0.01% 182
2015
Q4
$59K Hold
960
0.02% 180
2015
Q3
$61K Hold
960
0.02% 183
2015
Q2
$70K Sell
960
-144
-13% -$10.4K 0.02% 168
2015
Q1
$72K Buy
1,104
+849
+333% +$56.5K 0.02% 169
2014
Q4
$17K Sell
255
-393
-61% -$25.3K 0.01% 253
2014
Q3
$39K Sell
648
-3,989
-86% -$261K 0.01% 189
2014
Q2
$287K Buy
4,637
+1,959
+73% +$127K 0.11% 109
2014
Q1
$175K Sell
2,678
-1,959
-42% -$128K 0.07% 129
2013
Q4
$287K Sell
4,637
-215
-4% -$12.4K 0.11% 109
2013
Q3
$260K Sell
4,852
-5,748
-54% -$296K 0.12% 105
2013
Q2
$484K Buy
+10,600
New +$459K 0.23% 93

Other funds holding STJ

Central Bank & Trust's STJ Position: Q1 2017 in Review

Central Bank & Trust sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 960 shares — an estimated $77K sold.

Central Bank & Trust first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $484K in Q2 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Central Bank & Trust reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Central Bank & Trust sold 960 St Jude Medical shares in Q1 2017, an estimated $77K.
  • Central Bank & Trust first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Central Bank & Trust's St Jude Medical position peaked at $484K in Q2 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Central Bank & Trust's 13F filing for Q1 2017, filed 28 Apr 2017.